Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for December 07, 2011 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Renowned Psychiatrist Brings The Power Of Transcranial Magnetic Stimulation (TMS) To Manhattan's Financial District
Dr. Edward Fruitman, Director of Trifecta Health Medical Center in New York, New York, and renowned veteran in his field, is helping pioneer a cutting-edge, alternative treatment for depression known as TMS (Transcranial Magnetic Stimulation). 
x-small text small text medium text large text


    NEW YORK, NY, December 07, 2011 /24-7PressRelease/ -- Dr. Edward Fruitman, Director of Trifecta Health Medical Center in New York, New York, and renowned veteran in his field, is helping pioneer a cutting-edge, alternative treatment for depression known as TMS (Transcranial Magnetic Stimulation).

Dr. Edward Fruitman, is the first to bring the healing power of Transcranial Magnetic Stimulation to Manhattan's Financial District. As part of an elite few pioneering the innovative treatment for Depression, Dr. Fruitman and his team treat patients suffering from depression when other attempted methods have failed them or caused debilitating side-effects.

The Neurostar TMS system, which the FDA officially approved in October 2008 despite its being researched since the 1980s, uses highly focused, MRI strength magnetic pulses to stimulate neurons in the left prefrontal cortex. This in turn triggers the neurotransmitters in the targeted region, which activate the release of serotonin. TMS is typically administered five times a week over the course of four to six weeks for optimal likelihood and longevity of remission.

The device is especially designed for clinical use on an outpatient basis. Patients can return to normal activity immediately after each treatment because unlike its predecessor, electro convulsive therapy or ECT, TMS is completely non-invasive and no sedation is required, nor do patients experience the cognitive side effects or memory loss experienced post-ECT. Similarly, TMS offers an alternative solution to the adverse side effects caused by most traditional anti-depressants including weight gain, dry mouth, upset stomach, or even sexual dysfunction.

While clinical studies have found TMS to have about a 75 percent efficacy rate, Dr. Fruitman's success rate easily exceeds that of the national average. This is largely due to his approach, which integrates counseling as an option during TMS treatments when most other practitioners might leave a patient to be alone with their thoughts or simply even watching TV.

Dr. Fruitman is a Board Certified Psychiatrist and a nationally recognized expert in the field of psychopharmacology. Dr. Fruitman specializes in the treatment of Anxiety and Depression, as well as Adult ADD/ADHD at Trifecta Health Medical Center, where he is the first to introduce Transcranial Magnetic Stimulation (TMS) to New Yorks Financial District.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from Edward Fruitman:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Edward Fruitman
Trifecta Health Medical Center

Director
115 Broadway
New York, New York
United States 10006
Voice: (212) 233.2830
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.